FY2019 Earnings Estimate for DENTSPLY SIRONA Inc. (XRAY) Issued By Jefferies Group

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) – Investment analysts at Jefferies Group issued their FY2019 earnings estimates for shares of DENTSPLY SIRONA in a report released on Thursday. Jefferies Group analyst B. Couillard expects that the medical instruments supplier will earn $3.20 per share for the year. Jefferies Group has a “Buy” rating and a $66.00 price objective on the stock.

XRAY has been the subject of several other reports. BidaskClub lowered DENTSPLY SIRONA from a “sell” rating to a “strong sell” rating in a research report on Wednesday, August 16th. Zacks Investment Research upgraded DENTSPLY SIRONA from a “sell” rating to a “hold” rating in a research report on Friday, October 20th. Cleveland Research lowered DENTSPLY SIRONA from a “buy” rating to a “neutral” rating in a research report on Thursday, October 5th. UBS AG reiterated a “neutral” rating and issued a $59.00 price objective (down from $62.00) on shares of DENTSPLY SIRONA in a research report on Thursday, August 10th. Finally, Morgan Stanley reiterated an “overweight” rating and issued a $69.00 price objective (up from $67.00) on shares of DENTSPLY SIRONA in a research report on Friday, October 6th. Three equities research analysts have rated the stock with a sell rating, two have given a hold rating and seven have issued a buy rating to the stock. DENTSPLY SIRONA has a consensus rating of “Hold” and a consensus price target of $67.00.

COPYRIGHT VIOLATION WARNING: This story was originally posted by Markets Daily and is owned by of Markets Daily. If you are viewing this story on another domain, it was stolen and republished in violation of US and international trademark and copyright law. The original version of this story can be accessed at https://www.themarketsdaily.com/2017/11/14/fy2019-earnings-estimate-for-dentsply-sirona-inc-xray-issued-by-jefferies-group.html.

Shares of DENTSPLY SIRONA (XRAY) traded up $0.22 during trading on Monday, reaching $65.80. The company had a trading volume of 2,055,700 shares, compared to its average volume of 1,646,720. The stock has a market capitalization of $15,020.00, a price-to-earnings ratio of 26.13, a price-to-earnings-growth ratio of 2.60 and a beta of 1.27. DENTSPLY SIRONA has a 52 week low of $52.53 and a 52 week high of $67.95. The company has a quick ratio of 1.59, a current ratio of 2.32 and a debt-to-equity ratio of 0.21.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings results on Friday, November 3rd. The medical instruments supplier reported $0.70 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.66 by $0.04. The business had revenue of $1.01 billion during the quarter, compared to analyst estimates of $978.99 million. DENTSPLY SIRONA had a positive return on equity of 7.56% and a negative net margin of 20.33%. The business’s revenue was up 5.8% compared to the same quarter last year. During the same period in the prior year, the business earned $0.66 earnings per share.

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Vanguard Group Inc. boosted its position in shares of DENTSPLY SIRONA by 2.5% during the second quarter. Vanguard Group Inc. now owns 22,728,062 shares of the medical instruments supplier’s stock worth $1,473,688,000 after buying an additional 562,993 shares during the period. Ruane Cunniff & Goldfarb Inc. boosted its position in shares of DENTSPLY SIRONA by 0.5% during the third quarter. Ruane Cunniff & Goldfarb Inc. now owns 8,890,655 shares of the medical instruments supplier’s stock worth $531,750,000 after buying an additional 40,767 shares during the period. Principal Financial Group Inc. boosted its position in shares of DENTSPLY SIRONA by 6.7% during the third quarter. Principal Financial Group Inc. now owns 6,910,770 shares of the medical instruments supplier’s stock worth $413,333,000 after buying an additional 436,338 shares during the period. Jackson Square Partners LLC boosted its position in shares of DENTSPLY SIRONA by 15.6% during the third quarter. Jackson Square Partners LLC now owns 6,334,906 shares of the medical instruments supplier’s stock worth $378,890,000 after buying an additional 855,199 shares during the period. Finally, Veritas Asset Management LLP boosted its position in shares of DENTSPLY SIRONA by 2.6% during the second quarter. Veritas Asset Management LLP now owns 6,201,155 shares of the medical instruments supplier’s stock worth $402,083,000 after buying an additional 157,616 shares during the period. Institutional investors and hedge funds own 94.65% of the company’s stock.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Earnings History and Estimates for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply